Publisher
Springer International Publishing
Reference96 articles.
1. Abad MN, Calabuing-Farinas S, Lobo de Mena M et al (2021) Update on systemic treatment in early triple negative breast cancer. Ther Adv Med Oncol 13:1–18
2. AGO Breast Committee (2019) Diagnosis and treatment of patients with primary and metastatic breast cancer: recommendations. Available from: www.ago-online.de
3. Alba E, Chacon JI, Lluch A et al (2012) A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Res Treat 136(2):487–493
4. Aliabadi HM, Landry B, Mahdipoor P, Uludag H (2011) Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line. Mol Pharm 8:1821–1830
5. Ando M, Yamauchi H, Aogi K et al (2014) Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression. Breast Cancer Res Treat 145(2):401–409